Taipale, H. http://orcid.org/0000-0002-3281-934X
Rysä, J.
Hukkanen, J.
Koponen, M.
Tanskanen, A.
Tiihonen, J.
Kröger, H.
Hartikainen, S.
Tolppanen, A.-M.
Funding for this research was provided by:
University of Eastern Finland (UEF) including Kuopio University Hospital
Article History
Received: 24 January 2019
Accepted: 25 March 2019
First Online: 16 April 2019
Compliance with ethical standards
:
: HT, JT, and AT have participated in research projects funded by Janssen and Eli Lilly with grants paid to the institution where they were employed. JT has received personal fees from the Finnish Medicines Agency (Fimea), European Medicines Agency (EMA), Eli Lilly, Janssen-Cilag, Lundbeck, and Otsuka; and has received grants from the Stanley Foundation and Sigrid Jusélius Foundation. SH has received fees from Swedish Research Council. Other authors declare no conflicts of interest.
: Data were retrieved from the registers by the register maintainers and de-identified register data were submitted to the research team. Participants were not contacted in any way. According to Finnish legislation, no ethics committee approval is required in these circumstances.